Qiagen (NYSE:QGEN) Issues Quarterly Earnings Results, Meets Expectations

Key Points

• Qiagen reported quarterly earnings of $0.60 per share, meeting analysts' expectations, and updated its Q3 and FY 2025 earnings guidance.
• The company declared a dividend of $0.25 per share, reflecting a 52.0% dividend yield and a payout ratio of 62.50%.
• Analysts have varying ratings on Qiagen, with a consensus rating of Hold and a price target averaging $49.40, while Bank of America recently upgraded its price target to $53.00.

Qiagen (NYSE:QGEN - Get Free Report) released its earnings results on Tuesday. The company reported $0.60 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.60, Zacks reports. Qiagen had a return on equity of 14.61% and a net margin of 4.68%. Qiagen updated its Q3 2025 guidance to 0.580- EPS and its FY 2025 guidance to 2.350-2.350 EPS.

Qiagen Trading Down 0.7%

Shares of NYSE:QGEN traded down $0.34 during midday trading on Tuesday, hitting $49.91. 2,073,954 shares of the stock traded hands, compared to its average volume of 1,377,790. The stock has a market capitalization of $11.09 billion, a PE ratio of 125.14, a P/E/G ratio of 2.54 and a beta of 0.64. The business's 50 day moving average is $47.71 and its two-hundred day moving average is $43.46. The company has a quick ratio of 2.83, a current ratio of 3.37 and a debt-to-equity ratio of 0.40. Qiagen has a one year low of $37.63 and a one year high of $51.88.

Qiagen Dividend Announcement

The company also recently disclosed a dividend, which was paid on Thursday, July 10th. Stockholders of record on Thursday, July 3rd were paid a dividend of $0.25 per share. This represents a dividend yield of 52.0%. The ex-dividend date of this dividend was Wednesday, July 2nd. Qiagen's dividend payout ratio is 62.50%.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on QGEN. Bank of America raised their price objective on Qiagen from $50.00 to $53.00 and gave the company a "buy" rating in a report on Thursday, June 26th. Robert W. Baird raised their price objective on Qiagen from $42.00 to $43.00 and gave the company a "neutral" rating in a report on Monday, April 21st. Barclays assumed coverage on Qiagen in a report on Tuesday, June 24th. They set an "overweight" rating and a $55.00 price target for the company. Finally, Wall Street Zen upgraded Qiagen from a "buy" rating to a "strong-buy" rating in a report on Sunday. Seven research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, Qiagen currently has an average rating of "Hold" and a consensus price target of $49.40.

Hedge Funds Weigh In On Qiagen

An institutional investor recently bought a new position in Qiagen stock. United Services Automobile Association purchased a new position in Qiagen N.V. (NYSE:QGEN - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 5,946 shares of the company's stock, valued at approximately $239,000. 70.00% of the stock is owned by institutional investors.

Qiagen Company Profile

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.